Dataset for Emotional reaction to the first dose of COVID-19 vaccine: Post vaccination decline in anxiety and stress among anxious individuals and increase among individuals with normal anxiety levels pre vaccination

Although vaccinating the world is adopted by the WHO to limit COVID-19 transmission, people’s worries about vaccines may suppress their desire for vaccination despite vaccine availability. This study aimed to evaluate the levels of stress and anxiety among 250 Jordanians who received their first vaccine dose at a local community health center. The respondents completed the stress and anxiety subscales of the Depression Anxiety and Stress scale 21 (DASS-21) pre- and post-vaccination. The respondents expressed more moderate-severe levels of stress pre than post vaccination (20.8% and 13.2%, respectively). Meanwhile, 37.2% and 45.2% of the respondents expressed moderate-severe anxiety pre and post vaccination, respectively. Wilcoxon signed-rank test revealed that the drop in the level of stress from pre (median (IQR) = 5 (1-8)) to post vac-cination (median (IQR) = 3 (1-7)) was statistically significant (z = -3.81, p = 0.001, r = 0.17) while the increase in anxiety was not. Anxiety median significantly dropped among individuals experi-encing mild to severe anxiety pre vaccination. Similarly, stress and anxiety significantly increased among individuals expressing normal anxiety pre vaccination (z = -3.57 and -8.24, p values = 0.001, r = 0.16 and 0.37, respectively). Age positively correlated with post vaccination anxiety among respondents with mild pre vaccination anxiety, and it negatively correlated with pre vaccination level of stress in the normal anxiety group. Gender, marital status, respondents’ level of education, and history of COVID-19 infection had no significant correlation with anxiety or stress at either point of measurement. Overcoming their hesitancy to receive COVID-19 vaccine, individuals with normal levels of anxiety experienced a rise in their distress symptoms following immunization. On the contrary, vaccination seemed to desensitize anxious individuals. Policymakers need to formulate a population-specific plan to increase vaccine preparedness and promote psychological well-being over all during the pandemic.

尽管世界卫生组织采纳了全球疫苗接种策略以限制 COVID-19 的传播，但公众对疫苗的担忧可能抑制了他们在疫苗可用的情况下接种疫苗的意愿。本研究旨在评估250名在地方社区卫生中心接种首剂疫苗的约旦居民的焦虑和压力水平。受访者完成了疫苗接种前后抑郁、焦虑和压力量表21（DASS-21）的焦虑和压力子量表。受访者表示，在接种疫苗前后的焦虑和压力水平分别为中度至重度（分别为20.8%和13.2%）。同时，分别有37.2%和45.2%的受访者在接种疫苗前后表达了中度至重度的焦虑。Wilcoxon符号秩检验显示，从疫苗接种前的压力水平（中位数 [四分位数间距] = 5 [1-8]）到疫苗接种后的压力水平（中位数 [四分位数间距] = 3 [1-7]）的下降具有统计学意义（z = -3.81，p = 0.001，r = 0.17），而焦虑水平的增加则没有。在疫苗接种前经历轻度至重度焦虑的个人中，焦虑的中位数显著下降。同样，在疫苗接种前表现出正常焦虑水平的个人中，压力和焦虑水平显著增加（p值 = 0.001，r = 0.16和0.37，分别）。对于疫苗接种前焦虑水平正常的人群，年龄与疫苗接种后的焦虑水平呈正相关，而在正常焦虑组中，年龄与疫苗接种前的压力水平呈负相关。性别、婚姻状况、受访者的教育水平和COVID-19感染史在两个测量点均与焦虑或压力没有显著相关性。克服对接种 COVID-19 疫苗的犹豫，焦虑水平正常的个人在接种疫苗后其痛苦症状有所增加。相反，疫苗接种似乎使焦虑人群变得麻木。政策制定者需要制定针对特定人群的计划，以提高疫苗接种准备度并促进整个疫情期间的心理健康。